Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Dexcom (DXCM)

411   15.205 (3.84%) 10-24 14:01
Open: 398 Pre. Close: 395.795
High: 411.205 Low: 396.965
Volume: 534,976 Market Cap: 39,350M
DexCom, Inc. is a medical device manufacturing company. The company is headquartered in San Diego, California and currently employs 2,800 full-time employees. The firm is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The firm's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The firm is commercializing its fifth generation CGM system. The firm's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 411.899 - 413.867 413.867 - 415.653
Low: 392.129 - 394.412 394.412 - 396.484
Close: 407.178 - 410.991 410.991 - 414.452

Technical analysis

as of: 2020-10-23 4:42:55 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 490.56     One year: 572.97
Support: Support1: 391.21    Support2: 373.41
Resistance: Resistance1: 420.00    Resistance2: 490.56
Pivot: 393.53
Moving Average: MA(5): 396.91     MA(20): 395.80
MA(100): 408.22     MA(250): 321.97
MACD: MACD(12,26): -0.54     Signal(9): -2.38
Stochastic oscillator: %K(14,3): 55.17     %D(3): 45.67
RSI: RSI(14): 56.26
52-week: High: 456.23  Low: 149.46  Change(%): 171.1
Average Vol(K): 3-Month: 75527  10-Days: 74927

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
DXCM has closed below upper band by 0.0%. Bollinger Bands are 28.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 24 Oct 2020
Why buying the DexCom, Inc. (NASDAQ:DXCM) Stock Today Might Make Sense - Stocks Register

Fri, 23 Oct 2020
Is This The Calm Before The Storm On DexCom, Inc. (DXCM)? - Invest Million

Fri, 23 Oct 2020
Teladoc and DexCom: 2 stocks that are better buys than Apple - USA TODAY

Wed, 21 Oct 2020
DexCom (DXCM) Dips More Than Broader Markets: What You Should Know - Yahoo Finance

Wed, 21 Oct 2020
Were Hedge Funds Right About DexCom, Inc. (DXCM)? - Yahoo Finance

Wed, 21 Oct 2020
DexCom (DXCM) to Report Q3 Earnings: What's in the Cards? - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 96
Shares Float (M) 95
% Held by Insiders 0.44
% Held by Institutions 100.53
Shares Short (K) 3,820
Shares Short P. Month (K) 3,800

Stock Financials

EPS 2.160
EPS Est This Year -0.800
EPS Est Next Year -0.430
Book Value (p.s.) 14.190
Profit Margin 11.93
Operating Margin 16.03
Return on Assets (ttm) 6.2
Return on Equity (ttm) 20.0
Qtrly Rev. Growth 34.3
Gross Profit (p.s.) 9.729
Sales Per Share 17.965
EBITDA (p.s.) 3.267
Qtrly Earnings Growth
Operating Cash Flow (M) 394
Levered Free Cash Flow (M) 48

Stock Valuations

PE Ratio 190.28
PEG Ratio 2.01
Price to Book value 28.96
Price to Sales 22.88
Price to Cash Flow 99.82

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.